Non-small-cell lung cancers with kinase domain mutations in the epidermal growth factor receptor are sensitive to...

Area of Science:

• Oncology
• Radiation Oncology
• Molecular Biology

Background:

• Non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) tyrosine kinase domain (TKD) mutations shows sensitivity to EGFR inhibitors.
• The impact of acquired EGFR mutations on lung tumor response to ionizing radiation (IR) is not well understood.
• Understanding this interaction is crucial for optimizing NSCLC treatment.

Purpose of the Study:

• To investigate how EGFR mutations in NSCLC affect cellular response to ionizing radiation.
• To determine if EGFR mutations confer radiosensitivity in lung cancer cells.
• To explore the underlying mechanisms of radiosensitivity in mutant EGFR NSCLC.

Main Methods:

• Compared clonogenic survival of wild-type (WT) EGFR and mutant EGFR NSCLC cells after IR exposure.
• Exogenously expressed EGFR mutants (L858R, DeltaE746-E750) in human bronchial epithelial cells and NSCLC cell lines (A549, NCI-H1299).
• Assessed DNA repair kinetics, cell cycle arrest, apoptosis, and micronuclei formation post-IR.

Main Results:

• Mutant EGFR NSCLCs exhibited 500- to 1,000-fold reduced clonogenic survival compared to WT EGFR NSCLCs after IR.
• Exogenous expression of EGFR mutants significantly increased radiosensitivity in tested cell lines.
• Mutant EGFR NSCLCs, including those with T790M mutation, showed delayed DNA repair, defective IR-induced cell cycle arrest, and increased apoptosis/micronuclei.

Conclusions:

• Activating mutations in the EGFR TKD domain confer a radiosensitive phenotype to NSCLC.
• EGFR mutations are associated with impaired DNA repair and cell cycle control following IR.
• These findings offer insights into tailoring radiotherapy for NSCLC patients with specific EGFR mutations and potentially overcoming drug resistance.